A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CTVs

Search Conditions:
Search Keyword : CTVs
Search Method : Exact match.
Research Area:

Abbreviation: CTVs
Appearance Frequency: 123 time(s)
Long forms: 9

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
clinical target volumes
(111 times)
(75 times)
OARs (24 times)
CT (18 times)
IMRT (15 times)
2002 Irradiation of paranasal sinus tumors, a delineation and dose comparison study.
cancer terminator viruses
(3 times)
Cell Biology
(1 time)
PEG-Prom (2 times)
Ad (1 time)
CGT (1 time)
2006 Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy.
Clinical Target Volumes
(2 times)
(1 time)
GTVs (1 time)
HNSCC (1 time)
2017 Technical Note: Investigating the impact of field size on patient selection for the 1.5T MR-Linac.
clinical tumor volumes
(2 times)
(2 times)
cSMG (1 time)
iPG (1 time)
NTCP (1 time)
2009 Head-and-neck target delineation among radiation oncology residents after a teaching intervention: a prospective, blinded pilot study.
clinical treatment volumes
(1 time)
(1 time)
CNN (1 time)
CT (1 time)
DSC (1 time)
2020 Automatic contouring system for cervical cancer using convolutional neural networks.
Computed tomography venographies
(1 time)
Diagnostic Imaging
(1 time)
BVs (1 time)
SSS (1 time)
2012 Variations of the superior sagittal sinus and bridging veins in human dissections and computed tomography venography.
Contours of target volumes
(1 time)
(1 time)
ABAS (1 time)
DLBAS (1 time)
2020 Clinical evaluation of atlas- and deep learning-based automatic segmentation of multiple organs and clinical target volumes for breast cancer.
CT venograms
(1 time)
(1 time)
CVST (1 time)
HUs (1 time)
NCTs (1 time)
2015 Cerebral Venous Sinus Thrombosis, a Nonenhanced CT Diagnosis?
Cyclotriveratrylene analogues
(1 time)
(1 time)
--- 2012 Development of functionalized cyclotriveratrylene analogues: introduction of withdrawing and pi-conjugated groups.